ACUTAAS vs CHANDAN: Stock Comparison

ACUTAAS CHEMICALS vs CHANDANUpdated 18 Sept 26, 4:08 PM ISTNSE & company filings

ACUTAAS CHEMICALS is the larger company by market capitalisation. ACUTAAS CHEMICALS shows a higher ROE, faster revenue growth and lower leverage, while CHANDAN shows a lower P/E. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

ACUTAAS leads 10; CHANDAN leads 2 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

ACUTAASCHANDAN

Valuation lens

What price are you paying?

Market CapContext only
₹28,149 Cr
₹495 Cr
P/E RatioCHANDAN has the lower reading
72.89x
22.4x
P/B RatioCHANDAN has the lower reading
17.02x
3.55x
EPSACUTAAS has the higher reading
₹9.27
₹2.74
Book ValueContext only
₹208.96
₹72.1
Dividend YieldSame reading
0%
0%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
ACUTAAS is the larger company
₹28,149 Cr vs ₹495 Cr
P/E Ratio
CHANDAN has a lower P/E
22.4x vs 72.89x
P/B Ratio
CHANDAN has a lower P/B
3.55x vs 17.02x
EPS
ACUTAAS has higher earnings per share
₹9.27 vs ₹2.74
Revenue Growth (TTM YoY)
ACUTAAS has faster revenue growth
40.3% vs 0%
EPS Growth (TTM YoY)
ACUTAAS has faster EPS growth
105.6% vs 0%
Qtr Sales Growth
ACUTAAS has stronger quarterly sales growth
-2.2% vs -39.81%
Qtr Profit Growth
ACUTAAS has stronger quarterly profit growth
1.2% vs -10.49%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricACUTAASCHANDAN
SectorHealthcare
IndustryPharmaceuticals

Price

MetricACUTAASCHANDAN
Live Price₹3,440.3
Day Change3.78%
Volume5.21 L
52-Week High₹3,740
52-Week Low₹1,302
Distance from 52W High-8.01%

Valuation

MetricACUTAASCHANDAN
Market Cap₹28,149 Cr₹495 Cr
P/E Ratio72.89x22.4x
P/B Ratio17.02x3.55x
EPS₹9.27₹2.74
Book Value₹208.96₹72.1
Dividend Yield0%0%

Growth

MetricACUTAASCHANDAN
Revenue Growth (TTM YoY)40.3%0%
EPS Growth (TTM YoY)105.6%0%
Qtr Sales Growth-2.2%-39.81%
Qtr Profit Growth1.2%-10.49%

Profitability & Leverage

MetricACUTAASCHANDAN
ROE20.83%16.2%
ROCE23.33%14.55%
Net Margin26.6%0%
Operating Margin36.29%15.97%
Debt to Equity0.02x0.3x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricACUTAASCHANDAN
Promoter Holding32.66%49.61% 0.06 pp
FII Holding21.61% 2.13 pp0.01%
DII Holding19.56% 0.04 pp5.09% 0.06 pp
Public Holding26.16% 2.08 pp45.29% 0.13 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: ACUTAAS CHEMICALS and CHANDAN.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.